Efalizumab

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51201500
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51201539

This classification denotes an immunomodulator, an immunosuppressant, and monoclonal antibody, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XX2MN88N5D. Most nations schedule Efalizumab under HS 30021091 and SITC 54163. SMILES:. As of Q4 2014, EFALIZUMAB remains the US FDA Preferred Term for this commodity. . Efalizumab bears US NLM identifiers UMLS ID C1320125 and NCI Concept Code C68831.

Same parent

Under 51201500 · 15

51201516 Antilymphocyte or lymphocyte immune globulin Commodity 51201517 Guanidine Commodity 51201523 Anakinra Commodity 51201539 Efalizumab You are here 51201544 Glucosamine hcl Commodity 51201545 Gusperimus Commodity 51201547 Isatoribine Commodity 51201564 Sodium aurothiosulfate or sodium aurotiosulfate Commodity 51201569 Atlizumab or tocilizumab Commodity 51201571 Blinatumomab Commodity 51201572 Vedolizumab Commodity 51201573 Nivolumab Commodity 51201574 Palivizumab Commodity 51201575 Ixekizumab Commodity 51201576 Tofacitinib Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51200000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.